Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Alton O, Sartor"'
Publikováno v:
Mobile DNA, Vol 11, Iss 1, Pp 1-14 (2020)
Abstract Background Retrotransposons are one of the oldest evolutionary forces shaping mammalian genomes, with the ability to mobilize from one genomic location to another. This mobilization is also a significant factor in human disease. The only aut
Externí odkaz:
https://doaj.org/article/952bbcc3af784fe5946082bf5316a798
Autor:
Samer Ezziddin, Giovanni Paganelli, Jörg Elllinger, Gero Kramer, Alton O. Sartor, Avivit Peer, Martin Bögemann, John Sylvester, Jeffrey Meltzer, Per Sandström, Frank Verholen, Danny Y. Song, Luke T. Nordquist, Markus Essler, Christian la Fougère
Publikováno v:
Journal of Nuclear Medicine. 63:410-414
We analyzed real-world clinical outcomes of sequential alpha-/beta-emitter therapy for metastatic castration-resistant prostate cancer (mCRPC). Methods: We assessed safety and overall survival in 26 patients who received lutetium-177-prostate-specifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4fa7340dfb1e1c28118b1f5fcb18257
https://doi.org/10.2967/jnumed.121.262240
https://doi.org/10.2967/jnumed.121.262240
Autor:
Kambiz, Rahbar, Markus, Essler, Kim M, Pabst, Matthias, Eiber, Christian Peter, la Fougère, Vikas, Prasad, Philipp, Rassek, Ergela, Hasa, Helmut, Dittmann, Ralph A, Bundschuh, Wolfgang Peter, Fendler, Milena, Kurtinecz, Anja, Schmall, Frank, Verholen, Alton O, Sartor
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
The RAdium LUtetium (RALU) study evaluated the feasibility of sequential alpha and beta emitter use in patients with bone-predominant metastatic castration-resistant prostate cancer.This pre-planned, interim, retrospective analysis investigated safet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fe21c2514cebe95a5ef68841a4a26091
https://pubmed.ncbi.nlm.nih.gov/36302656
https://pubmed.ncbi.nlm.nih.gov/36302656
Publikováno v:
BJU International. 109:311-315
What’s known on the subject? and What does the study add? There is little known on how to objectively measure renal ischemia during partial nephrectomy. This study clemonstrates two potentially useful methods to measure renal ischemia during partia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b05668386c41f5431eda9157d7d437a3
https://doi.org/10.1111/j.1464-410x.2011.10260.x
https://doi.org/10.1111/j.1464-410x.2011.10260.x
Autor:
Landon W. Trost, Ege Serefoglu, Ahmet Gokce, Gökçe, Ahmet, Brian J. Linder, Alton O. Sartor, Wayne J. G. Hellstrom
Publikováno v:
The journal of sexual medicine. 10
Introduction Androgen deprivation therapy (ADT) is commonly utilized in the management of both localized and advanced adenocarcinoma of the prostate. The use of ADT is associated with several adverse events, physical changes, and development of medic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b5223da89371c848223d83f3bfa0c6b
https://pubmed.ncbi.nlm.nih.gov/24112553
https://pubmed.ncbi.nlm.nih.gov/24112553
Publikováno v:
Journal of Urology. 185
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6dc7f9962bac3c47b506f8b882d6712a
https://doi.org/10.1016/j.juro.2011.02.862
https://doi.org/10.1016/j.juro.2011.02.862